Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective
Objectives: To perform a budget impact analysis (BIA) of the adoption of baricitinib for the management of alopecia areata (AA) by a Saudi public sector payer. Methods: A BIA model was developed to calculate the expected financial impact under two scenarios: the baseline scenario, which reflects the...
Saved in:
| Main Authors: | A. Alshahrani, S. Al-Aqeel, M. Alshahrani, S. Alqahtani, S.T. Alhawwashi, M.S. Al-Nasser, M. Zaitoun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Saudi Pharmaceutical Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S131901642400255X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of baricitinib in treatment of coexisting alopecia areata and lichen planopilaris
by: Adaugo A. Sanyi, MD, et al.
Published: (2025-02-01) -
Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
by: Sihan Wang, et al.
Published: (2025-01-01) -
Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
by: Carlo A. Vignoli, et al.
Published: (2025-12-01) -
Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
by: Akihiko Uchiyama, et al.
Published: (2025-01-01) -
Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
by: Abraham Zlotogorski, et al.
Published: (2024-12-01)